Improved clinical efficacy found wanting in Phase III IMPALA trial
This key finding has shaped the future direction for the drug as Mologen AG has confirmed that it will only...
Trending menu:
-
![New, efficacious options offer hope for Ebola treatment and containment]()
New, efficacious options offer hope for Ebola treatment and containment
-
![GSK’s Zejula meets primary goal in Phase III ovarian cancer trial]()
GSK’s Zejula meets primary goal in Phase III ovarian cancer trial
-
![Trials data suggests Cosentyx from Novartis will change psoriasis market]()
Trials data suggests Cosentyx from Novartis will change psoriasis market
-
![Eligibility criteria for clinical trials report challenges in representing LN patients]()
Eligibility criteria for clinical trials report challenges in representing LN patients
-
![Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities]()
Celltrion implements Veeva Vault eTMF to improve visibility into clinical trial activities
-
![Longboat Clinical launches Patient CONNECT to ease patient recruitment process]()
Longboat Clinical launches Patient CONNECT to ease patient recruitment process
Expert commentary & analysis from GlobalData
Eisai leads charge to develop dementia biologics
Gene therapy pipeline for neurology indications dominated by viral vectors
Aurinia still has potential Phase III lupus nephritis mortality risk
Zolgensma and Spinraza may face spinal muscular atrophy market shortfall
Most Read
Company releases
Pharmaceutical Drug Development and Particle Sizing
Typically, when an individual is suffering from minor ailments at home, such as a headache, heartburn or a common cold,...
Sometimes, You Have to Move to Go Forward
Inocure at Electrospin, China
Inocure presented at the 6th International Conference on Electrospinning in China.
See Malvern Panalytical’s Upcoming Webinars
Pfanstiehl to Attend Two Events in August
Pfanstiehl has announced that it will be sponsoring the 2019 Colorado Protein Stability Conference.
Company whitepapers
Study: Comparing Efficacy and Tolerability of New Daily Oral Vitamin B12 and Intermittent Intramuscular Vitamin B12
Primary Cells Isolated from Healthy Human and Animal Tissues
STZ-Induced Rat Model of Diabetes
Noble Life SciencesUnderstanding Sucrose: Matching Sucrose Quality to Functional Need
PfanstiehlClinical Trials: Gene Therapy
GlobalDataClinical Trials: A Round-Up of 2018
GlobalDataProtein Sciences Platform
Company A-Z
Clinical Trials
Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN
Biopharmaceutical firm Retrophin has reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients.
MyoKardia starts dosing hypertrophic cardiomyopathy patients
Amgen and Allergan report positive data from lymphoma drug trial
Aimmune begins enrolling egg allergy patients in Phase II study
Oxurion reports mixed results from Phase IIa DME study
Drug Development
Retrophin’s fosmetpantotenate fails in Phase III trial for PKAN
Biopharmaceutical firm Retrophin has reported that the Phase III clinical trial of fosmetpantotenate failed to meet endpoints in pantothenate kinase-associated neurodegeneration (PKAN) patients.
ViiV’s long-acting HIV regimen passes late-stage trial
Fulcrum launches Phase IIb trial of losmapimod to treat FSHD
Synlogic terminates development of ammonia lowering drug
Lynparza improves survival in Phase III ovarian cancer patients
Go Top